Therefore, a novel mechanism in diabetic nephropathy may be the activation of the UPP, which increases ubiquitin degradation of Smad7, which is a inhibiting factor in the TGF-β/SMAD signaling pathway. The gene discussed is TGFB1; the disease is diabetic kidney disease.